Dr. Adam Gregory is a Partner and Patent Attorney at Mewburn Ellis LLP. He works with biotech companies to build and manage their patent portfolios, drafting patent applications and co-ordinating prosecution worldwide. In this episode, he highlights success stories from Singapore’s vibrant biotech scene, including Enleofen Bio and Hummingbird Bioscience, and discusses the evolving nature of patent strategies in the face of emerging technologies like AI and gene editing. From understanding the differences between patents, trademarks, and copyrights to exploring the patent application process and common pitfalls, this episode is packed with valuable information for anyone in the biotech industry. Host: John Joson NgEditors: Jessie Wong, johEditors: Jessie Wong, John Joson Ng The show notes and transcripts for the episode can be found on nucleatesingapore.substack.com. For feedback or recommendations on who we should talk to next, please reach out to Joson Ng via [email protected]. 01:02 - Introduction08:50 - The patent application process14:57 - Strategic IP management and common pitfalls27:06 - Success stories from Singapore biotech36:18 - Emerging technologies and future trends